Cahira Technologies

Cahira Technologies Inc is an MIT spinoff company founded by Prof. Deblina Sarkar (https://web.mit.edu/deblina-sarkar/). We have built the world’s first autonomous and non-surgical electronic implant for treating intractable neural diseases and for human augmentation. Problem: Human potential is constrained by diseases and limitations posed by biology. According to the World Health Organization, over 3 billion people suffer from different neural disorders. Drugs are mostly ineffective, and typical implants are limited to only about 1% of patients, due to surgery costs, complications and risks. Beyond diseases, biological restrictions such as our limited number of neurons and the way they process information, constrain human capabilities. Our Solution: Autonomous, non-surgical brain implants. Tech is already de-risked in clinical animal studies and has won multiple awards. Our nanoelectronic devices can be introduced into the body without surgery and can autonomously implant in target brain regions. They co-live and co-exist with the brain cells enabling brain-computer symbiosis fusing into biology the capabilities of AI powered electronics. Impact: According to the World Health Organization, over 3 billion people suffer from neural disorders. However, today's surgical brain implants help <1% of patients due to their invasiveness, risks, and costs. By eliminating surgery, we are making our life-changing treatment accessible to all, removing barriers of age, health status, and cost that currently prevent millions from receiving treatment. Beyond treating diseases, our unique brain-computer symbiosis, can enhance humans through precise modulation/enhancement of brain signals as well as drastically increasing neural density with synthetic electronic neurons which can communicate with each other and with the biological neurons for an augmented brain, transcending humans beyond biological limitations.